| Term 
 
        | Direct acting Cholinergic agonists |  | Definition 
 
        | Bethanechol (Urecholine) Pilocarpine (Isopto Carpine, Pilocar)
 Cevimeline (Evoxac)
 Nicotine
 Varenicline (Chantix)
 |  | 
        |  | 
        
        | Term 
 
        | Cholinesterase Inhibitors "Indirect acting"
 increase ACh @ M and N receptors
 |  | Definition 
 
        | Edrophonium (Tensilon) Neostigmine (prostigmin)
 Physostigmine (Eserine)
 Echothiophate
 Doneprezil (Aricept)
 Organophosphates
 Pralidoxime (2-PAM)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atropine Scopolamine (transderm scop)
 Glycopyrrolate (Robunil)
 Dicylomine (Bentyl)
 Tolterodine (Detrol)
 Oxybutynin (Ditropan)
 Darifenacine (Enablex)
 Ipratropium (Atrovent)
 Tropicamide (Mydriacil)
 Benzotropine (congentin)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct-acting cholinergic agonist -selective for M receptors
 -activates G-protein-IP3-DAG-ca-proteinK
 -does not cross BB barier
 -effects seen most in Urinary & GI ( most commonly used to stimulate peristalsis)
 -M2 binding=inhibitory (dec adenylyl cyclase)
 |  | 
        |  | 
        
        | Term 
 
        | Pilocarpine (Isopto Carpine, Pilocar) |  | Definition 
 
        | Direct-acting cholinergic agonist -Most common Cholinergic Glaucoma treatment (closed-w/ cholinesterase inhibitor & open)
 -specific for M receptors
 -activates G-protein-IP3-DAG-Ca-proteinK
 -well absorbed
 -gets into brain easily
 -big effect on Sweat & salivary glands-profuse seating w/ M1 receptors
 -M2=inhibitory (dec adenylyl cyclase)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct-acting cholinergic agonist -selective for M3 receptors
 -activates G-protein-IP3-DAG-Ca-proteinKin
 -M2=inhibitory (dec adenylyl cyclase)
 -Commonly used to increase salivation in treatment of Sjogren's syndrome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct acting cholinergic agonist -selective for N receptors
 -help people quit smoking
 -due to autonomic ganglion stim-get firing of PNS & SNS
 -cardiac: maily sympathetic
 -GI: mainly parasympathetic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct acting cholinergic agonist -partial agonist on brain N receptors
 -help people quit smoking: low levels of DA, blocks effects of nicotine if smokes
 -Side effects: nausea, vomiting, GI, sleep disturbance, nightmares, psychosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinesterase inhibitor -must be injected
 -binds reversibly, short duration of action (5-10min)
 -quaternary ammonium compound
 -diagnosis of myasthenia gravis!
 -reversal of neuromuscular blockade in surgery
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinesterase inhibitor -covalent bond (30min-6hrs)
 -quaternary amine, not well absorbed orally
 -treat chronic Myasthenia gravis! (orally)
 -doesn't cross BB barrier
 -OLD drug for paralytic ileus/atony of bladder-not used anymore
 -reversal of neuromuscular blockade in surgery
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinesterase inhibitor -covalent bond (30min-6hrs)
 -tertiary amine, absorbed orally
 -will get into Brain bad CNS effects, so NOT used orally
 -directly in eye to treat open angle glaucoma!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinesterase inhibitor -is an organophosphate
 -long duration of action
 -long term control of intraocular pressure (can be used for open angle glaucoma)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinesterase inhibitor -absorbed orally, get into brain
 -treat Alzheimer's disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinesterase inhibitor -highly lipid soluble
 -long lasting bond.  "AGING"-becomes irreversible.
 -2PAM can prevent aging if added soon enough
 -if aging not prevented-poisoning can be fatal!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinesterase inhibitor -given to treat Organophosphate poisoning (prevent aging)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinergic antagonist -treat Organophosphate/carbamate poisoning (irreversible cholinesterase inhibitors)
 -does not enter CNS well until high doses
 -salivary, sweat glands, bronchial tissues affected at low doses
 -ANS, Heart, GI-high doses
 -reverse effects of reflex vagal discharge
 -reverse bradycardia produced by M agonists or cholinesterase inhibitors
 -in MI to decrease bradycardia or AV block
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinergic antagonist -enters CNS easily (can get toxic psychosis)
 -sedation, amnesia
 -absorbed through skin as well
 -treat/prevent motion sickness
 -pre-anesthetic regimen.  sedation, amnesia, dry secretions
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinergic antagonist -prevent vagal response during surgery
 -decrease muscharinic side effects w/ myasthenia gravis treatments
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinergic antagonist -inhibits motility and secretions in GI track
 -antispasmodic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinergic antagonist -M3 antagonist
 -treat overactive bladder, bladder spasms
 -not lipid soluble, few CNS side effects
 -Preferred drug of elderly
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinergic antagonist -prevent bladder spasm after prostate surgery
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinergic antagonist -competitive, M3 antagonist
 -treat overactive bladder
 -taken orally, has many drug metabolism interations (CYP2D6 & CYP3A4)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinergic antagonist -quaternary ammonium compound
 -not well absorbed, effects limited to lung
 -bronchodilation (COPD)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinergic antagonist -short-acting mydriasis & cycloplegia (eye exams)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholinergic antagonist -used to restore balance between Ach & DA (antipsychotic drugs, parkinson's disease)
 -decrease extrapyramidal symptoms
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Epinephrine (Adrenalin) Norephinephrine (Levophed)
 Isoproterenol (Isuprel)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Phenylephrine (Neo-synephrine) Pseudoephedrine (Sudafed)
 Oxymetazoline (Afrin)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Clonidine (catapres) Apraclonidine (Iopidine)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Albuterol (Ventolin) Ritrodine (Yutopar)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dopamine (Intropin) Fenodolpam (corlopam)
 |  | 
        |  | 
        
        | Term 
 
        | "other" adrenergic stimulants |  | Definition 
 
        | Ephedrine Amphetamine
 Cocaine
 Tyramine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Catecholamine -affect alpha1 (excitatory-IP3-DAG-PKC) & alpha2 (inhibitory-inhibit adenylyl cyclase-dec cAMP) receptors
 -High affinity for B2 receptors
 -effect depends on dose administered
 -overall: increase in PP, little change in overall pressure, Inc HR
 -Inc Rein secretion (B1)
 -Bronchodilation (B2)-emergency asthma treatment
 -treat anaphylactic shock
 -emergency treatment of cardiac arrest, and complete heart block
 -treat glaucoma, inc removal and dec production of aqueous humor
 -decrease diffusion of local anesthetics
 |  | 
        |  | 
        
        | Term 
 
        | Norepinephrine (Levophed) |  | Definition 
 
        | Catecholamine -affect alpha1 & alpha2 & B1 receptors
 -little effect on B2 receptors!
 -more effect on B3 receptors
 -must be injected, rapid metabolism
 -vasoconstriction-inc TPR-inc BP
 -DBP & SBP increase, little change to PP
 -if atopine given before-vagal reflex inhibited-HR will increase
 -NE can cause severe vasoconstriction & then necrosis at infusion site
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Catecholamine -potent selectie B1 & B2 agonist
 -does not work on alpha receptors
 -used in emergency treatment for cardiac arrest and complete heart block
 -sort increase in BP, overall DEC in BP
 *lg doses can cause tachycardia, palpitations, arrhythmias
 -high affinity for all B receptors
 |  | 
        |  | 
        
        | Term 
 
        | Phenylephrine (Neo-synephrine) |  | Definition 
 
        | Alpha agonist -alpha 1 selective
 -vasoconstriction-increases TPR-INC BP-reflex dec HR
 -used in hypotensive emergency to raise BP
 -careful w/ hypertensive pts
 -mydriasis w/o affecting accommodation for eye exams
 |  | 
        |  | 
        
        | Term 
 
        | Pseudoephedrine (Sudafed) |  | Definition 
 
        | Alpha agonist -OTC decongestant prep
 -use w/ caution w/ hypertension (may inc BP)
 -can be used to make Meth
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha agonist -used topically as nasal sprays as decongestants
 -rebound effects (down regulated receptors)
 -also works on alpha-2 receptors-can cause hypotension in lg quantity
 **contraindicated in narrow-angle glaucoma & Hypertension**
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-2 agonist -inhibit NE release
 -reduced sympathetic output-dec BP
 -orally or transdermal patch
 -used in treatment of hypertension
 -pre anesthetic medication
 -side effects: sexual dysfunction, dry mouth, sedation, avoid getting patch too hot!
 -rebound hypertension could occur if drug withdrawn abruptly
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-2 agonist -inhibit transmitter release
 -used in eye: dec intraocular pressure by reducing formation of aqueous humor
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-1 agonist -Increase force & rate of heart contraction (+ inotropic)
 -used in cardiac stress tests
 -very short acting (1/2 life=2min)
 -Increase AV conduction
 -increase renin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-2 agonist -cardiac effects less pronounced
 -relax respiratory, uterine, blood vessels in skeletal muscle (dec TPR)
 -treat Asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-2 agonist -relaxes uterus (suppresses premature labor)
 -given orally or IV
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -stimulates Alpha & Beta receptors, enhances NE release -similar effect as epinephrine-but less pronounced
 -long acting, CNS stimulant, inc HR, inc BP, bronchodilation
 -found in many weight loss products-taken off market due to bad side effects & death
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -indirect acting.  Increases NE release -CNS stimulant: inc alertness, dec need for sleep, dec appetite, euphoria, inc motor activity
 -tachycardia, hypertension
 -psychosis
 -Strong contraction of urinary bladder-has been used to treat enuresis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -inhibits re-uptake of DA and NE -indirect acting
 -shorter acting, more intense than amphetamine
 -side effets: HTN, addicting, stroke, arrhythmias, MI, psychosis
 -sometimes used as vasoconstrictor for nasopharyngeal surgery.  local anesthesia & dec blood flow.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -indirectly acting.  Inc release of NE & DA from nerve terminals **Pts treated for depression w/ MAO-Inhibitors-injestion of lg amounts may cause severe hypertensive crisis!!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dopamine agonist -D1 at low doses (vasodilation, inc renal blood flow)
 -B1 at high concentrations
 -treat cardiac shock, increase CO w/o causing vasoconstriction
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dopamine agonist -Selective D1 receptor agonist
 -dilation of vascular beds, dec BP
 -used to produce rapid dec in BP w/ severe hypertension
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Phentolamine (regitine) Phenoxybenzamine (dibenzyline)
 |  | 
        |  | 
        
        | Term 
 
        | Alpha1 Selective Blockers |  | Definition 
 
        | Prazosin (minipress) Terazosin (hytrin)
 Doxazosin (cardura)
 Alfuzosin (uroxatral)
 Tamsulosin (Flomax)
 |  | 
        |  | 
        
        | Term 
 
        | Alpha2 Selective Blockers |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Propranolol (Inderal) Timolol (Timoptic)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Metoprolol (lopressor) Atenolol (tenormin)
 Esmolol (brevibloc)
 Betaxolol (betoptic)
 |  | 
        |  | 
        
        | Term 
 
        | Beta-blockers w/ Intrinsic Sympathetic Activity |  | Definition 
 
        | Pindolol (visken) Acebutolol (sectral)
 |  | 
        |  | 
        
        | Term 
 
        | Combined Alpha & Beta blockers |  | Definition 
 
        | Labetalol (normodyne) Carvedilol (coreg)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-receptor blocker -reversible competitive alpha 1&2 antagonist
 -almost never used b/c of amount and severity of side effects (tachycardia, arrhythmias, MI, hypotension, abdominal pain, peptic ulcer exacerbation)
 -may be used short-term treatment for hypertensive crisis in pheochromocytoma
 -may be used to prevent necrosis if vasoconstrictor (NE) accidently is injected into tissues
 |  | 
        |  | 
        
        | Term 
 
        | Phenoxybenzamine (dibenzyline) |  | Definition 
 
        | Alpha-receptor blocker -irreversible antagonist (covalent bond)
 -almost never used
 -mainly used to treat pheochromocytoma
 -tachycardia may occur, hypotension severe if hypovolemic, postrual hypotension, inhibit ejaculation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-1 selective blocker -reversible antagonist
 -less likely to increase HR
 -relaxes arterial & venus smooth muscle, dec TPR, BP dec, also lack of a2 blockage reduces likelihood of reflex tachycardia
 -dec LDL & TG, inc HDL
 *1/2 life doubled in CHF (dec dose)
 -given 2x a day (not perscribed as much)
 -treatment of hypertension
 -treatment of Benign prostatic hyperplasia
 -Perfect for HTN & BPH together!!
 
 Side effects:
 -first does phenomenon (is worst)
 -inhibits ejaculation, ED
 -dizziness, postural hypotension, nasal stuffiness
 **postural hypotension SEVERE if combined w/ Viagra!**
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-1 selective blocker -similar to Prazosin
 -only given ONCE a day (better choice)
 -1st dose phenomenon
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-1 receptor blocker -similar to Prazosin
 -only given ONCE a day (better choice)
 -1st dose phenomenon
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-1 receptor blocker -treats BPH
 -not as selective as Tamsulosin
 -improves urine flow, little effect on BP
 -but causes dizziness
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-1 receptor blocker -little effect on BP
 -treat BPH!! relaxes prostate & sphincer
 -side effect: difficulty ejaculating
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-2 receptor blocker -herbal preparation
 -increases NE release
 -BP and HR increase
 -"natrual viagra?"
 **dangerous to use when have hypertension-will interfere w/ efect of Clonidine**
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-receptor blocker -competitive antagonist, equal affinity for B1& B2 receptors
 -slows HR, dec force of contraction
 -slows conduction
 -dec renin release
 -dec lipolysis & glycogenolysis
 -local anesthetic (blocks Na+ channels at higher doses)
 -low bioavilibity, high first pass, variable between pts-monitor
 -crosses BBB easily, CNS side effects of sedation, depression may occur
 -Chronic use: dec BP, dec mortality in post MI pts
 -treat hypertension (not 1st choice)
 -treat angina
 -treat arrhythymias
 -treat hyperthyroidism
 -dec risk of bleeding in cirrhosis
 -revent migranes, reduce tremor, and stage fright
 
 Side effects:
 **NOT recommended for Asthmatics**
 -bradycardia, rebound htn, mask symptoms of hypoglycemia
 *CCB w/ BB might produce additive effects=good
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor blocker -treat Glaucoma (topical)
 -absorbed systemically-so should not be used w/ Ashtmatics
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-1 receptor blocker -Treat Hypertension
 -better exercise tolerance than non-selective BB
 -increased life expectancy post MI
 -migrane prophylaxis
 -Risky w/ asthmatics
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-1 receptor blocker -Treat Hypertension
 -better exercise tolerance than non-selective BB
 -increased life expectancy post MI
 -migrane prophylaxis
 -Risky w/ asthmatics
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-1 blocker -very short duration of action
 -must be injected intravenously
 -used in urgent situations where rapid effect is needed, or rapid removal of BB effect (HF, bc, Hypotension)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-1 receptor blocker -treatment of glaucoma (better choice)
 -less likely to cause bronchoconstriction when used in eye than timolol!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-blocker w/ ISA activity -non-selective B blocker
 -used to treat hypertension and angina
 -risk of bradycardia lower
 -may not affect plasma lipids
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-blocker w/ ISA activity -Selective B1 antagonist
 -used to treat hypertension and angina
 -risk of bradycardia lower
 -may not affect plasma lipids
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Combined alpha & beta blocker -alpha 1 blockade: relaxation of arterial smooth muscle and DEC BP
 -B1 blockade: prevents compensatory inc HR (so better than a-blocker alone?)
 -treatment of hypertension (orally)
 -hypertensive emergencies (intravenously)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Combined alpha & beta blocker -non selective beta blocker w/ A1 block
 -vasodilation, DEC BP, w/o tachycardia
 -treatment of hypertension
 -improves morbidity in CHF pts
 -seide effects of all B & A blockers=pts don't like the feel
 |  | 
        |  |